167 related articles for article (PubMed ID: 17327280)
1. The ADMA/DDAH pathway is a critical regulator of endothelial cell motility.
Wojciak-Stothard B; Torondel B; Tsang LY; Fleming I; Fisslthaler B; Leiper JM; Vallance P
J Cell Sci; 2007 Mar; 120(Pt 6):929-42. PubMed ID: 17327280
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Rac1 activity by ADMA/DDAH regulates pulmonary endothelial barrier function.
Wojciak-Stothard B; Torondel B; Zhao L; Renné T; Leiper JM
Mol Biol Cell; 2009 Jan; 20(1):33-42. PubMed ID: 18923147
[TBL] [Abstract][Full Text] [Related]
3. The ADMA/DDAH pathway regulates VEGF-mediated angiogenesis.
Fiedler LR; Bachetti T; Leiper J; Zachary I; Chen L; Renné T; Wojciak-Stothard B
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2117-24. PubMed ID: 19778944
[TBL] [Abstract][Full Text] [Related]
4. The DDAH/ADMA pathway in the control of endothelial cell migration and angiogenesis.
Fiedler LR; Wojciak-Stothard B
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1243-7. PubMed ID: 19909255
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
Sakurada M; Shichiri M; Imamura M; Azuma H; Hirata Y
Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the endothelial DDAH/ADMA pathway in nitroglycerin tolerance: the role of ALDH-2.
Zhang GG; Shi RZ; Jiang DJ; Chen YR; Jia-Chen ; Tang ZY; Bai YP; Xiao HB; Li YJ
Life Sci; 2008 Mar; 82(13-14):699-707. PubMed ID: 18289604
[TBL] [Abstract][Full Text] [Related]
7. cAMP phosphodiesterase inhibitors increases nitric oxide production by modulating dimethylarginine dimethylaminohydrolases.
Pullamsetti SS; Savai R; Schaefer MB; Wilhelm J; Ghofrani HA; Weissmann N; Schudt C; Fleming I; Mayer K; Leiper J; Seeger W; Grimminger F; Schermuly RT
Circulation; 2011 Mar; 123(11):1194-204. PubMed ID: 21382892
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
Feng M; Liu L; Guo Z; Xiong Y
Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
[TBL] [Abstract][Full Text] [Related]
9. CT-1 induces angiogenesis by regulating the ADMA/DDAH Pathway.
Zheng ZZ; Tian Fu X; Liang J; Bing Guo Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):540-6. PubMed ID: 25732979
[TBL] [Abstract][Full Text] [Related]
10. Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton.
Bijman MN; van Nieuw Amerongen GP; Laurens N; van Hinsbergh VW; Boven E
Mol Cancer Ther; 2006 Sep; 5(9):2348-57. PubMed ID: 16985069
[TBL] [Abstract][Full Text] [Related]
11. Regulation by DDAH/ADMA pathway of lipopolysaccharide-induced tissue factor expression in endothelial cells.
Xin HY; Jiang DJ; Jia SJ; Song K; Wang GP; Li YJ; Chen FP
Thromb Haemost; 2007 May; 97(5):830-8. PubMed ID: 17479195
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T
Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151
[TBL] [Abstract][Full Text] [Related]
13. Dimethylarginine dimethylaminohydrolase 1 modulates endothelial cell growth through nitric oxide and Akt.
Zhang P; Hu X; Xu X; Chen Y; Bache RJ
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):890-7. PubMed ID: 21212404
[TBL] [Abstract][Full Text] [Related]
14. Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production.
Pope AJ; Karrupiah K; Kearns PN; Xia Y; Cardounel AJ
J Biol Chem; 2009 Dec; 284(51):35338-47. PubMed ID: 19820234
[TBL] [Abstract][Full Text] [Related]
15. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
Liu LH; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
Cell Physiol Biochem; 2012; 30(6):1413-22. PubMed ID: 23171931
[TBL] [Abstract][Full Text] [Related]
16. The DDAH/ADMA pathway is a critical regulator of NO signalling in vascular homeostasis.
Fiedler L
Cell Adh Migr; 2008; 2(3):149-50. PubMed ID: 19270535
[TBL] [Abstract][Full Text] [Related]
17. Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats.
Sasaki A; Doi S; Mizutani S; Azuma H
Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1480-7. PubMed ID: 17322279
[TBL] [Abstract][Full Text] [Related]
18. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
Lin KY; Ito A; Asagami T; Tsao PS; Adimoolam S; Kimoto M; Tsuji H; Reaven GM; Cooke JP
Circulation; 2002 Aug; 106(8):987-92. PubMed ID: 12186805
[TBL] [Abstract][Full Text] [Related]
19. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
Tan B; Jiang DJ; Huang H; Jia SJ; Jiang JL; Hu CP; Li YJ
Vascul Pharmacol; 2007 May; 46(5):338-45. PubMed ID: 17293168
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
Dayoub H; Rodionov RN; Lynch C; Cooke JP; Arning E; Bottiglieri T; Lentz SR; Faraci FM
Stroke; 2008 Jan; 39(1):180-4. PubMed ID: 18063827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
